Author

Andreas Stallmach 1

1 Medizin. Universität Jena

Addendum to S3-Guidelines Crohn’s disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic – open questions and answers

Andreas Stallmach

Clinical Advances of Infliximab in IBD treatment: Infliximab SC (Celltrion Healthcare)

Stefan  Schreiber, Subrata Gosh, Andreas Stallmach

ENCAPSULATED FECAL MICROBIOTA TRANSFER IN PATIENTS WITH CHRONIC, ANTIBIOTIC–REFRACTORY POUCHITIS

Andreas Stallmach

ENCAPSULATED FECAL MICROBIOTA TRANSFER IN PATIENTS WITH CHRONIC, ANTIBIOTIC–REFRACTORY POUCHITIS

Arndt Steube, Marius Vital, Andreas Sturm, Carsten Buening, Andreas Stallmach, Dietmar Pieper

IDENTIFICATION OF RELEVANT PATIENT REPORTED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - LISTEN I

Niels Teich, Hermann Schulze, Jana Knop, Michael Obermeier, Andreas Stallmach

LONG-TERM TREATMENT WITH FERRIC MALTOL IS EFFECTIVE AND WELL TOLERATED IN CORRECTING IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM A PHASE-3 OPEN-LABEL STUDY

Carsten Schmidt, Tariq Ahmad, Zsolt Tulassay, Daniel C. Baumgart, Bernd Bokemeyer, Stefanie Howaldt, Andreas Stallmach, Carsten Büning

MOLECULAR INVESTIGATIONS BY RAMAN IMAGING FOR A RELIABLE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA

Tatiana Tolstik, Claudio Marquardt, Christian Matthäus, Claudia Beleites, Christiane Bielecki, Christoph Krafft, Olaf Dirsch, Juergen Popp, Andreas Stallmach

MUCOSAL PHOSPHTIDYLCHOLINE AND LYSOPHOSPHATIDYLCHOLINE CONCENTRATIONS ARE REDUCED IN SEPSIS INDUCED MUCOSAL BARRIER DYSFUNCTION

Carsten Schmidt, Christian Lautenschläger, Annika Gauss, Otmar Huber, Wolfgang Stremmel, Andreas Stallmach

QAX576, AN ANTI–INTERLEUKIN (IL)-13 MONOCLONAL ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH FISTULISING CROHN’S DISEASE (CD): RESULTS OF A PROOF-OF-CONCEPT STUDY

Gerhard Rogler, Andreas Stallmach, Stefan Fichtner-Feigl, Stefan Schreiber, Andreas Sturm, Emma Ramsden, Pierre Moulin, David Lee, Andreas Christ

ST10, A NOVEL ORAL FERRIC IRON, IS AN EFFECTIVE AND WELL-TOLERATED TREATMENT FOR IRON DEFICIENCY ANAEMIA IN IBD PATIENTS WHO FAIL TO RESPOND OR TOLERATE ORAL FERROUS PREPARATIONS: RESULTS FROM THE PHASE 3 STUDY PROGRAM

Christoph Gasché, Zsolt Tulassay, Andreas Stallmach, Julian Howell

Item 1 - 10 / 28
1
2 3